Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 المشاهدات
• 06/28/23
0
0
تضمين
administrator
مشتركين
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
أظهر المزيد
تعليقات الفيسبوك
SORT BY-
أعلى تعليقات
-
أحدث تعليقات